Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs

Roughly 70% of the new patients are taking Lilly medicines, with Zepbound emerging as the main beneficiary, CEO Dave Ricks said.

Summary by CNBC
They're the latest metrics on how much the new Medicare coverage is expanding access to GLP-1 medicines since it launched in July.

4 Articles

CNBCCNBC
+2 Reposted by 2 other sources
Lean Left

Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs

They're the latest metrics on how much the new Medicare coverage is expanding access to GLP-1 medicines since it launched in July.

·Englewood Cliffs, United States
Read Full Article
SpaceMoneySpaceMoney

Lilly Sees 70% of New GLP-1 Patients in Medicare

According to CNBC, CEO of Eli Lilly claims that 700,000 new beneficiaries of Medicare have started GLP-1 since July and 70% use medicines from the company

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

CNBC broke the news in Englewood Cliffs, United States on Monday, September 21, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Medicare icon

Medicare

Eli Lilly icon

Eli Lilly

Medical icon

Medical

GLP-1 icon

GLP-1

United States icon

United States

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal